Australia Stock Exchange release from NOXOPHARM : Initial Director's Interest Notice - GM
31/01/2022 21:25
Australia Stock Exchange release from NOXOPHARM NOX.AX : Initial Director's Interest Notice - GM
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer